Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 138   

Articles published

GSK 1,452.00 -7.00 (-0.48%)
price chart
GlaxoSmithKline Plc (NYSE:GSK) Targeting Blockbuster Sales With Shingles ...
GlaxoSmithKline Plc (NYSE:GSK) has moved to expand the target market for its blockbuster vaccine, Shingrix, with the filing of a regulatory application in Europe.
GlaxoSmithKline (NYSE:GSK) Files Regulatory Application for Shingrix in EU  Benchmark Monitor
Better Buy: AbbVie Inc. vs. GlaxoSmithKline PLC
During most of 2016, when shares of AbbVie (NYSE:ABBV) went up, so did shares of GlaxoSmithKline (NYSE:GSK). However, after the U.S.
What Smart Money Thinks About GlaxoSmithKline plc (ADR) (GSK)
Is GlaxoSmithKline plc (ADR) (NYSE:GSK) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Trading Corner: Eye on Technical Levels for GlaxoSmithKline PLC (GSK.L)
Investors are tracking indicators on shares of GlaxoSmithKline PLC (GSK.L). The current 14-day RSI is 31.18, the 7-day is at 26.96, and the 3-day is resting at 19.78.
What should you know before buying GlaxoSmithKline plc (LSE:GSK) for its dividend
There is a lot to be liked about GlaxoSmithKline plc (LSE:GSK) as an income stock, over the past 10 years it has returned an average of 4.92% per year.
GlaxoSmithKline plc (ADR) Could Decline a Lot According to The Today's ...  Frisco Fastball
Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?  AOL Money UK
Why did shares in Hikma Pharmaceuticals plc and GlaxoSmithKline plc crash last ...
Since the beginning of October, shares in GlaxoSmithKline(LSE GSK) and Hikma(LSE: HIK) have been on the retreat. After a rally during the first six months of the year (shares in Glaxo and Hikma rose 20% and 15% respectively in H1), since the beginning ...
GlaxoSmithKline's shingles vaccine filed in Europe
Dr Emmanuel Hanon, Glaxo's head of Vaccines R&D, said the vaccine has consistently shown high efficacy in older people in its phase III development programme.
GSK announces EU regulatory submission of Shingles candidate vaccine  RTT News
Stock In The Spotlight: GlaxoSmithKline PLC (NYSE:GSK)
Sell-side analysts maintain a positive outlook on the shares of GlaxoSmithKline PLC (NYSE:GSK). Based on the poll results published by the Zacks Research as of 2016-12-04, the stock of the company has been assigned an ABR of 1.86 rating, where ...
Worth Watching Stocks: The Blackstone Group L.P. (NYSE:BX), GlaxoSmithKline ...
The company announced its last quarter financial performance results on 10/27/2016. The Blackstone Group L.P. (NYSE:BX) belongs to Finance sector that surged 1.59% in value when last trading session closed at $26.15.
GlaxoSmithKline PLC (NYSE:GSK) Mean Price Target At $48.25
GlaxoSmithKline PLC (NYSE:GSK) mean price target is $48.25. Thomson Reuters averaged equity recommendations specified by analysts in census planned by First Call.